Catherine Badour
Finland’s Wartsila and U.S. peer Cummins are interested in potentially buying General Electric’s (GE) 3 billion euro ($3.6 billion) distributed power operations, which GE is looking to sell to bolster its finances, sources told Reuters.
In an industry undergoing consolidation, privately-owned Swiss exchange SIX sees potential takeover targets in Iberia and central Europe and has itself been approached by potential buyers, Chief Executive Officer Jos Dijsselhof told Reuters in an interview.
French insurer AXA (AXAF.PA) on Thursday priced the forthcoming initial public offering (IPO) of its U.S. division at $24-27 per share, in a deal that could value the part of the business being listed on the market at $3.5 billion, Reuters reported.
Brazilian shoemaker Dass Nordeste Calçados e Artigos Esportivos SA has decided to cancel its initial public offering because of weak demand, a source told Reuters.
Ping An’s Good Doctor online healthcare platform has raised $1.12 billion in its initial public offering, pricing its shares at the top of its range in Hong Kong’s largest new listing this year, sources told Reuters.
Private equity-backed cyber security firm Avast is targeting a market capitalization of between 2.5 billion and 3.2 billion pounds ($3.5-4.5 billion) in its initial public offering (IPO), potentially the biggest London listing since July, Reuters reported.
U.S. cable company Comcast Corp submitted a 22 billion pound ($31 billion) offer for pay-TV group Sky (SKYB.L) on Wednesday, challenging an already agreed but lower takeover bid from Rupert Murdoch’s Fox (FOXA.O), Reuters reported.
The private equity funds of Blackstone (BX.N) and Apollo (APO.N) are the only two bidders left in the sale of Spanish gaming hall operator Cirsa, raising doubts about whether the sale will go ahead, Reuters reported.
Bankrupt department store chain Bon-Ton Stores Inc (BONTQ.PK) said on Tuesday it received a winning bid from a joint venture, including Great American Group and Tiger Capital Group, to wind down its operations, Reuters reported.
French healthcare group Sanofi (SASY.PA) is in exclusive talks to sell its Zentiva European generics drugs arm to private equity firm Advent International for 1.9 billion euros ($2.4 billion), the companies said on Tuesday.